Two Sigma Advisers’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.94M | Buy |
1,139,800
+388,600
| +52% | +$1.34M | 0.01% | 827 |
|
|
2025
Q1 | $1.97M | Buy |
751,200
+112,300
| +18% | +$294K | ﹤0.01% | 1162 |
|
|
2024
Q4 | $2.63M | Buy |
638,900
+24,700
| +4% | +$102K | 0.01% | 1003 |
|
|
2024
Q3 | $4.35M | Buy |
614,200
+189,400
| +45% | +$1.34M | 0.01% | 755 |
|
|
2024
Q2 | $2.77M | Buy |
424,800
+30,500
| +8% | +$199K | 0.01% | 1019 |
|
|
2024
Q1 | $3.27M | Buy |
394,300
+64,700
| +20% | +$537K | 0.01% | 965 |
|
|
2023
Q4 | $3.63M | Buy |
329,600
+24,400
| +8% | +$269K | 0.01% | 964 |
|
|
2023
Q3 | $2.57M | Buy |
305,200
+290,800
| +2,019% | +$2.45M | 0.01% | 1063 |
|
|
2023
Q2 | $181K | Buy |
14,400
+2,600
| +22% | +$32.7K | ﹤0.01% | 2116 |
|
|
2023
Q1 | $194K | Sell |
11,800
-29,800
| -72% | -$491K | ﹤0.01% | 2276 |
|
|
2022
Q4 | $622K | Buy |
41,600
+22,100
| +113% | +$330K | ﹤0.01% | 1791 |
|
|
2022
Q3 | $436K | Buy |
+19,500
| New | +$436K | ﹤0.01% | 1897 |
|